AC
CVS icon

Arjuna Capital’s CVS Health CVS Stock Holding History

Arjuna Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17M Sell
20,962
-471
-2% -$42K 0.49% 57
2026
Q1 		$1.54M Buy
21,433
+581
+3% +$44.8K 0.39% 63
2025
Q4 		$1.65M Sell
20,852
-84
-0.4% -$6.62K 0.41% 61
2025
Q3 		$1.58M Buy
+20,936
New +$1.43M 0.39% 63
2024
Q4 		– Sell
-6,206
Closed -$390K – 103
2024
Q3 		$390K Sell
6,206
-54,208
-90% -$3.16M 0.1% 84
2024
Q2 		$3.57M Buy
60,414
+1,143
+2% +$71.5K 0.96% 32
2024
Q1 		$4.73M Buy
59,271
+2,204
+4% +$168K 1.34% 26
2023
Q4 		$4.51M Buy
57,067
+16,683
+41% +$1.19M 1.41% 22
2023
Q3 		$2.82M Buy
40,384
+1,051
+3% +$74.5K 1.01% 29
2023
Q2 		$2.72M Buy
39,333
+20,394
+108% +$1.45M 0.96% 32
2023
Q1 		$1.41M Sell
18,939
-25,910
-58% -$2.17M 0.55% 51
2022
Q4 		$4.18M Buy
44,849
+615
+1% +$59.3K 1.93% 13
2022
Q3 		$4.22M Buy
44,234
+14
+0% +$1.39K 2.07% 14
2022
Q2 		$4.1M Buy
44,220
+1,431
+3% +$140K 1.98% 18
2022
Q1 		$4.33M Buy
42,789
+2,983
+7% +$313K 1.81% 17
2021
Q4 		$4.11M Buy
39,806
+1,803
+5% +$167K 1.5% 20
2021
Q3 		$3.23M Buy
38,003
+10,782
+40% +$903K 1.31% 23
2021
Q2 		$2.27M Buy
27,221
+3,678
+16% +$301K 0.98% 31
2021
Q1 		$1.77M Buy
23,543
+1,200
+5% +$87.4K 0.87% 38
2020
Q4 		$1.53M Buy
22,343
+1,017
+5% +$66.1K 0.84% 39
2020
Q3 		$1.25M Buy
21,326
+423
+2% +$26.3K 0.77% 42
2020
Q2 		$1.36M Buy
20,903
+623
+3% +$39.2K 0.94% 38
2020
Q1 		$1.2M Buy
+20,280
New +$1.35M 1% 36
2019
Q2 		– Sell
-10,354
Closed -$558K – 96
2019
Q1 		$558K Sell
10,354
-498
-5% -$30.7K 0.43% 65
2018
Q4 		$711K Buy
10,852
+149
+1% +$11.1K 0.65% 50
2018
Q3 		$843K Buy
10,703
+1,902
+22% +$136K 0.63% 52
2018
Q2 		$566K Buy
+8,801
New +$580K 0.46% 63

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Arjuna Capital's CVS Position: Q2 2026 in Review

Arjuna Capital reduced its CVS Health (CVS) stake by 2.2% in Q2 2026, selling an estimated $42K and leaving 20,962 shares worth $2.17M. The position accounts for 0.49% of the portfolio, ranked #57.

Arjuna Capital first reported a position in CVS in Q2 2018 and has held it in 27 quarters since. The position peaked at $4.73M in Q1 2024. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Arjuna Capital held 20,962 shares of CVS Health worth $2.17M as of Q2 2026.
  • Arjuna Capital sold 471 CVS Health shares in Q2 2026, an estimated $42K.
  • CVS Health made up 0.49% of Arjuna Capital's portfolio in Q2 2026, its #57 holding.
  • Arjuna Capital first reported a position in CVS Health in Q2 2018 and has held it in 27 quarters since.
  • Arjuna Capital's CVS Health position peaked at $4.73M in Q1 2024.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Arjuna Capital's 13F filing for Q2 2026, filed 14 Aug 2026.